Uroplasty, Inc. (UPI) to Announce Fiscal Fourth Quarter And Full Year 2013 Financial Results on May 30, 2013
5/21/2013 6:30:14 AM
More...
|
Uroplasty, Inc. (UPI) Announces STEP Study 3-Year Results Demonstrate Sustained Therapeutic Effects of Percutaneous Tibial Nerve Stimulation
5/10/2013 9:48:14 AM
More...
|
Uroplasty, Inc. (UPI) CEO Steps Down
4/5/2013 9:05:02 AM
More...
|
Uroplasty, Inc. (UPI) to Present at the 25th Annual ROTH Growth Stock Conference
3/7/2013 6:56:13 AM
More...
|
Uroplasty, Inc. (UPI) Announces Several Presentations on Urgent® PC to be Delivered at Upcoming Professional Society Meetings
2/26/2013 8:47:11 AM
More...
|
Uroplasty, Inc. (UPI) Announces Executive Changes in US Sales Organization
2/6/2013 9:09:44 AM
More...
|
Uroplasty, Inc. (UPI) Executives Unfazed Over Competition From Allergan Inc. (AGN)'s Botox to Treat Overactive Bladder
1/28/2013 8:36:22 AM
More...
|
Uroplasty, Inc. (UPI) Reports Fiscal Third Quarter 2013 Financial Results
1/25/2013 6:35:52 AM
More...
|
Uroplasty, Inc. (UPI) to Issue Third Quarter of Fiscal 2013 Financial Results on January 24, 2013
1/15/2013 6:29:06 AM
More...
|
Uroplasty, Inc. (UPI) Release: Study Demonstrates Percutaneous Tibial Nerve Stimulation Offers More Cost-Effective OAB Treatment Than Sacral Nerve Stimulation
12/6/2012 9:30:47 AM
More...
|
|